期刊
NATURE GENETICS
卷 48, 期 4, 页码 356-+出版社
NATURE PORTFOLIO
DOI: 10.1038/ng.3503
关键词
-
资金
- Translational and Integrative Medicine Research Fund
- Cycle for Survival
- Josie Robertson Foundation
- Marie-Josee and Henry R. Kravis Center for Molecular Oncology
- Sloan Kettering Institute for Cancer Research Cancer Center [P30CA008748]
Plasmacytoid bladder cancer is an aggressive histologic variant with a high risk of disease-specific mortality. Using whole-exome and targeted sequencing, we find that truncating somatic alterations in the CDH1 gene occur in 84% of plasmacytoid carcinomas and are specific to this histologic variant. Consistent with the aggressive clinical behavior of plasmacytoid carcinomas, which frequently recur locally, CRISPR/Cas9-mediated knockout of CDH1 in bladder cancer cells enhanced cell migration.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据